Word: cardiologists
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
CAPTURED. Bernard C. Welch Jr., 45, convicted master burglar and murderer sentenced to 143 years to life after the 1980 killing of Washington Cardiologist Michael Halberstam; by police in Greensburg, Pa., a suburb of Pittsburgh, who followed up a routine parking violation and ended a manhunt that began May 14, when Welch and a fellow inmate escaped from a Chicago jail while he was supposedly helping federal agents prevent a breakout planned by others. Found in a stolen car and in an apartment occupied by Welch were seven pistols, seven rifles and $500,000 worth of antiques, indicating that Welch...
...surprised the doctors who examined these patients was that none of them had actually suffered a heart attack. Indeed, few had any signs of heart disease at all. Yet at least five of the 19--and perhaps more--would have died without treatment, according to Dr. Ilan Wittstein, the cardiologist who led the study...
...hypertension; 160/100 is Stage 2 hypertension; 220/120 is the onset of what is known as malignant hypertension, pressure so high that fluid is squeezed from vessels into the brain and blood leaks out of capillaries into the liquid that fills the eyeballs. "Malignant hypertension is a medical emergency," says cardiologist Richard Devereux of Cornell University Medical College...
Johnson & Johnson felt much the same way in the mid-1990s about its new business selling stents, the tiny devices used to prop open clogged arteries. With a virtual monopoly of the billion-dollar business, J&J alienated many of its cardiologist customers by charging high prices and failing to develop a new generation of product. When competitors like Guidant and Boston Scientific came out with their own stents, customers were eager to abandon J&J (which has admitted being slow to innovate but denies that its pricing was at fault). Says Sydney Finkelstein, a professor at Dartmouth's Tuck...
...hasn't been tested as long, but so far the data look good. Two more COX-2 inhibitors, Arcoxia (from Merck) and Prexige (from Novartis), are awaiting FDA approval. "Obviously, we now have to look more carefully at the other members of the class," says Dr. Steven Nissen, a cardiologist at the Cleveland Clinic who voiced his concerns about Vioxx several years...